Login / Signup

Rituximab for rheumatoid arthritis-related interstitial lung disease: A systematic review and meta-analysis.

Tarun Krishna BoppanaTarun Krishna BoppanaKaran MadanAnant MohanVijay HaddaRandeep Guleria
Published in: Archives of rheumatology (2024)
Treatment with rituximab in RA-ILD was associated with a significant improvement in %-predicted FVC, as well as stabilization or improvement in ILD after one year of treatment.
Keyphrases
  • interstitial lung disease
  • rheumatoid arthritis
  • systemic sclerosis
  • idiopathic pulmonary fibrosis
  • diffuse large b cell lymphoma
  • disease activity
  • combination therapy